Insights

Regenerative Medicine Focus Surrozen's focus on regenerative medicines targeting the body's self-renewal properties through Wnt signaling pathway control presents opportunities in the growing field of personalized medicine and tissue regeneration.

Leading-edge Scientific Founders Founded by top scientists with deep expertise in Wnt signaling, Surrozen's leadership team enhances its credibility and opens doors for collaborations with research institutions and academic partners seeking innovative therapeutic approaches.

Venture Capital Backing Backed by The Column Group, a prominent biotechnology venture capital firm, Surrozen's financial stability and strategic support indicate potential for expansion, partnerships, and accelerated product development.

Technological Proficiency Utilizing a tech stack that includes modern tools like Webpack and OpenResty, Surrozen demonstrates technological competence that can be leveraged to enhance customer engagement, streamline processes, and differentiate offerings in the market.

Targeted Hiring and Growth As Surrozen actively seeks creative scientists to join its team, there are opportunities for suppliers of recruitment services and training programs to engage with the company and support its growth trajectory in the competitive biotechnology research landscape.

Surrozen Tech Stack

Surrozen uses 8 technology products and services including jQuery CDN, Handlebars, Webpack, and more. Explore Surrozen's tech stack below.

  • jQuery CDN
    Content Delivery Network
  • Handlebars
    Javascript Frameworks
  • Webpack
    Miscellaneous
  • Open Graph
    Miscellaneous
  • Module Federation
    Miscellaneous
  • Webflow
    Page Builders
  • Akamai Web Application Protector
    Security
  • OpenResty
    Web Servers

Media & News

Surrozen's Email Address Formats

Surrozen uses at least 1 format(s):
Surrozen Email FormatsExamplePercentage
First@surrozen.comJohn@surrozen.com
79%
FLast@surrozen.comJDoe@surrozen.com
14%
Last@surrozen.comDoe@surrozen.com
4%
FiLast@surrozen.comJoDoe@surrozen.com
3%

Frequently Asked Questions

Where is Surrozen's headquarters located?

Minus sign iconPlus sign icon
Surrozen's main headquarters is located at 171 Oyster Point Blvd South San Francisco, California 94080 US. The company has employees across 2 continents, including North AmericaAsia.

What is Surrozen's stock symbol?

Minus sign iconPlus sign icon
Surrozen is a publicly traded company; the company's stock symbol is SRZNW.

What is Surrozen's official website and social media links?

Minus sign iconPlus sign icon
Surrozen's official website is surrozen.com and has social profiles on LinkedIn.

How much revenue does Surrozen generate?

Minus sign iconPlus sign icon
As of November 2024, Surrozen's annual revenue reached $7.5M.

What is Surrozen's SIC code NAICS code?

Minus sign iconPlus sign icon
Surrozen's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Surrozen have currently?

Minus sign iconPlus sign icon
As of November 2024, Surrozen has approximately 74 employees across 2 continents, including North AmericaAsia. Key team members include Chief Operating Officer: C. W.Chief Medical Officer: G. V.Head Of Culture And Leadership: C. C.. Explore Surrozen's employee directory with LeadIQ.

What industry does Surrozen belong to?

Minus sign iconPlus sign icon
Surrozen operates in the Biotechnology Research industry.

What technology does Surrozen use?

Minus sign iconPlus sign icon
Surrozen's tech stack includes jQuery CDNHandlebarsWebpackOpen GraphModule FederationWebflowAkamai Web Application ProtectorOpenResty.

What is Surrozen's email format?

Minus sign iconPlus sign icon
Surrozen's email format typically follows the pattern of . Find more Surrozen email formats with LeadIQ.

How much funding has Surrozen raised to date?

Minus sign iconPlus sign icon
As of November 2024, Surrozen has raised $18M in funding. The last funding round occurred on Apr 01, 2024 for $18M.
Surrozen

Surrozen

Biotechnology ResearchCalifornia, United States51-200 Employees

Surrozen is a biotechnology company focused on discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the Wnt signaling pathway.

Surrozen was founded by five leading-edge scientists: K. Christopher Garcia, Ph.D., Roel Nusse, Ph.D. and Calvin Kuo, M.D., Ph.D. from Stanford University; Claudia Janda, Ph.D. from the Princess Maxima Center for Pediatric Oncology; and Hans Clevers, M.D, Ph.D. from the Hubrecht Institute and Princess Maxima Center. Each has conducted extensive research on Wnt signaling, with findings that together shape Surrozen’s technology and approach to therapeutic development. The company is backed by The Column Group, a leading biotechnology venture capital firm.

We are currently seeking highly creative scientists to join our team, and invite you to explore career opportunities on our website.

Section iconCompany Overview

Headquarters
171 Oyster Point Blvd South San Francisco, California 94080 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
SRZNW
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $18M

    Surrozen has raised a total of $18M of funding over 5 rounds. Their latest funding round was raised on Apr 01, 2024 in the amount of $18M.

  • $10M

    Surrozen's revenue is in the range of $10M

Section iconFunding & Financials

  • $18M

    Surrozen has raised a total of $18M of funding over 5 rounds. Their latest funding round was raised on Apr 01, 2024 in the amount of $18M.

  • $10M

    Surrozen's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.